Journal
JOURNAL OF RHEUMATOLOGY
Volume 46, Issue 10, Pages 1409-1414Publisher
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.181071
Keywords
OMERACT; RHEUMATIC DISEASES; OUTCOMES
Categories
Funding
- Children's Hospital of Eastern Ontario Research Institute
- Arthritis Society
- US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH) [K23-AR-064372]
- NIAMS, part of the NIH [AR060231-01]
- Oak Foundation [OCAY-13-309]
- Northern Sydney Local Health District
- La Trobe University
Ask authors/readers for more resources
Objective. The Outcome Measures in Rheumatology (OMERACT) Shared Decision Making (SDM) Working Group aims to determine the core outcome domain set for measuring the effectiveness of SDM interventions in rheumatology trials. Methods. A white paper was developed to clarify the draft core domain set. It was then used to prepare for interviews to investigate reasons for lack of consensus on it and to suggest further improvements. Results. OMERACT scientists/clinicians (n = 13) and patients (n = 10) suggested limiting the core domain set to outcome domains, removing process domains, and clarifying remaining domains. Conclusion. A revised core domain set will undergo further consensus-building.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available